Purinoceptor modulation of noradrenaline release in rat tail artery: Tonic modulation mediated by inhibitory P-2Y- and facilitatory A(2A)-purinoceptors

被引:51
作者
Goncalves, J
Queiroz, G
机构
[1] Department of Pharmacology, Faculty of Pharmacy, University of Porto, 4050 Porto, Rua Anibal Cunha
关键词
rat tail artery; modulation of noradrenaline release; endogenous adenosine; A(1)-adenosine receptor; A(2A)-adenosine receptor; P-2Y-purinoceptor;
D O I
10.1111/j.1476-5381.1996.tb15168.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of analogues of adenosine and ATP on noradrenaline release elicited by electrical stimulation (5 Hz, 2700 pulses) were studied in superfused preparations of rat tail artery. The effects of purinoceptor antagonists, of adenosine deaminase and of adenosine uptake blockade were also examined. Noradrenaline was measured by h.p.l.c, electrochemical detection. 2 The A(1)-adenosine receptor agonist, N-6-cyclopentyladenosine (CPA; 0.1-100 nM) reduced, whereas A(2A)-receptor agonist 2-p-(2-carboxyethyl)phenelhylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680; 3-30 nM) increased evoked noradrenaline overflow. These effects were antagonized by the A(1)-adenosine receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 20 nM) and the A(2)-adenosine receptor antagonist, 3,7-dimethyl-1-propargylxanthine (DMPX; 100 nM), respectively. The P-2Y-purinoceptor agonist, 2-methylthio-ATP (1-100 mu M) reduced noradrenaline overflow, an effect prevented by the P-2-purinoceptor antagonist, cibacron blue 3GA (100 mu M) and suramin (100 mu M). 3 Adenosine deaminase (2 u ml(-1)), DMPX (100 nM) and inhibition of adenosine uptake with S-(p-nitrobenzyl)-6-thioinosine (NBTI; 50 nM) decreased evoked noradrenaline overflow. DPCPX alone did not change noradrenaline overflow but prevented the inhibition caused by NBTI. The P-2Y-purinoceptor antagonist, cibacron blue 3GA (100 mu M) increased evoked noradrenaline overflow as did suramin, a nonselective P-2-antagonist. 4 It is concluded that, in rat tail artery, inhibitory (A(1) and P-2Y) and facilitatory (A(2A)) purinoceptors are present and modulate noradrenaline release evoked by electrical stimulation. Endogenous purines tonically modulate noradrenaline release through activation of inhibitory P-2Y and facilitatory A(2A) purinoceptors, whereas a tonic activation of inhibitory A(1) purinoceptors seems to be prevented by adenosine uptake.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 38 条
[1]   P-2 PURINOCEPTORS MODULATING NORADRENALINE RELEASE FROM SYMPATHETIC NEURONS IN CULTURE [J].
ALLGAIER, C ;
PULLMANN, F ;
SCHOBERT, A ;
VONKUGELGEN, I ;
HERTTING, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 252 (02) :R7-R8
[2]   THE ADENOSINE RECEPTOR-MEDIATED INHIBITION OF NORADRENALINE RELEASE POSSIBLY INVOLVES A N-PROTEIN AND IS INCREASED BY ALPHA-2-AUTORECEPTOR BLOCKADE [J].
ALLGAIER, C ;
HERTTING, G ;
KUGELGEN, OV .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (02) :403-412
[3]   ATP ACTIVATES P2X-CONTRACTING AND P2Y-RELAXING PURINOCEPTORS IN THE SMOOTH-MUSCLE OF MOUSE VAS-DEFERENS [J].
BOLAND, B ;
HIMPENS, B ;
VINCENT, MF ;
GILLIS, JM ;
CASTEELS, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (04) :1152-1158
[4]   ANALOGS OF CAFFEINE AND THEOPHYLLINE - EFFECT OF STRUCTURAL ALTERATIONS ON AFFINITY AT ADENOSINE RECEPTORS [J].
DALY, JW ;
PADGETT, WL ;
SHAMIM, MT .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (07) :1305-1308
[5]   POSSIBLE FEEDBACK INHIBITION OF NORADRENALINE RELEASE BY PURINE COMPOUNDS [J].
ENERO, MA ;
SAIDMAN, BQ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 297 (01) :39-46
[6]  
FORSYTH KM, 1991, J PHARMACOL EXP THER, V256, P821
[7]  
FUDER H, 1992, N-S ARCH PHARMACOL, V345, P417
[8]  
FUDER H, 1993, N-S ARCH PHARMACOL, V348, P352
[9]   AUTOREGULATION OF NEUROMUSCULAR-TRANSMISSION IN THE GUINEA-PIG SAPHENOUS ARTERY [J].
FUJIOKA, M ;
CHEUNG, DW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (02) :147-153
[10]  
GONCALVES J, 1993, N-S ARCH PHARMACOL, V348, P367